Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients. (2022). Precision Medicine Communications, 2(2), 91-108. https://doi.org/10.55627/pmc.002.02.0188